Bristol-Myers Squibb Co. (NYSE:BMY)

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

January 3, 2019: The S&P 500 closed down 2.5% at 2,447.96. The DJIA closed down 2.8% at 22,686.36. Separately, the Nasdaq closed down 3.0% at 6,463.50. Thursday was a down ...
Read Full Story »

Apple, Bristol-Myers Plummet into Thursday’s 52-Week Low Club

January 3, 2019: Here are four stocks trading with heavy volume among 66 equities trading at new 52-week lows shortly before Thursday's closing bell. On the NYSE, decliners led advancers ...
Read Full Story »

Bristol-Myers, Celgene to Tie a $74 Billion Knot

There's nothing like spending $74 billion on an acquisition to get shareholders' attention. That's what Bristol-Myers Squibb Co. (NYSE: BMY) found out Thursday morning following the announcement of a definitive ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, American Water, Apple, Facebook, Macy’s, Southern Copper, Twitter, YY and Many More

Stocks were set to open lower on Thursday after Wednesday's market closures. The drop is on the heels of what already felt like a buyer's strike of a major sell-off ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb Co. (NYSE: BMY) shares dipped on Tuesday after the company reported results from its late-stage lung cancer study. The firm announced that its Phase 3 CheckMate 451 study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

How Compugen Is Weathering Thursday’s Storm

Compugen Ltd. (NASDAQ: CGEN) shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb Co. (NYSE: BMY) will make a $12 million equity investment as part of its ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »